NVP-BKM120 hydrochloride

CAS No. 1312445-63-8

NVP-BKM120 hydrochloride ( BKM-120 hydrochloride;Buparlisib hydrochloride )

Catalog No. M11254 CAS No. 1312445-63-8

A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 176 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NVP-BKM120 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms.
  • Description
    A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms with IC50 of 52 nM/166 nM/116 nM/262 nM for p110α/β/δ/γ, respectively; much less effectively inhibits the class III PI3K Vps34 and mTOR, and has no effect on PI4Kβ and several other kinases; prevents the growth of assorted cancer cell lines when used at 5 μM and inhibits tumor growth in vivo.Blood Cancer Phase 2 Clinical
  • Synonyms
    BKM-120 hydrochloride;Buparlisib hydrochloride
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    1312445-63-8
  • Formula Weight
    446.85
  • Molecular Formula
    C18H22ClF3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4.Cl
  • Chemical Name
    2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-, hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Maira SM, et al. Mol Cancer Ther. 2012 Feb;11(2):317-28.
2. Pei Y, et al. Cancer Cell. 2012 Feb 14;21(2):155-67.
3. Koul D, et al. Clin Cancer Res. 2012 Jan 1;18(1):184-95.
molnova catalog
related products
  • AS-252424

    AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.

  • PF-04979064

    A highly potent and selective, dual PI3K/mTOR inhibitor.

  • Loureirin A

    Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin.